Market Cap 1.71B
Revenue (ttm) 123.67M
Net Income (ttm) -38.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -31.24%
Debt to Equity Ratio 0.00
Volume 740,097
Avg Vol 1,025,544
Day's Range N/A - N/A
Shares Out 84.48M
Stochastic %K 20%
Beta 1.62
Analysts Strong Sell
Price Target $32.17

Company Profile

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of i...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 949 2643
Address:
321 Harrison Avenue, Suite 900, Boston, United States
MorganHoratio
MorganHoratio May. 8 at 1:36 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: $HYPR - 898,720 $LYEL - 293,256 $MAZE - 1,388,583 $GLUE - 684,275 $OSCR - 481,988 Google's Q1 13F reveals a sharp focus: Cybersecurity Bedrock + AI Bio-Engineering! The stake in $HYPR is a massive signal—in a 2026 defined by AI deepfakes, Google is leaning on $HYPR's passwordless tech to fortify its Gemini ecosystem. Meanwhile, the heavy lifting in $MAZE and $GLUE proves Alphabet is no longer just indexing information, but indexing "cures" through AI-led protein modeling. With $OSCR hitting its profitability inflection point, do you think Google is just building an AI-health moat, or are we looking at the early days of its next multi-billion dollar "Other Bet" breakout? Let's discuss your top small-cap pick!
3 · Reply
LabPsycho
LabPsycho May. 7 at 4:49 PM
$GLUE Frankly, IMO, while the cash and some of their assets look good, I dont get why they are going after: hidradenitis suppurativa (arent there easy do it at home ways to address much of this?) and atherosclerosis - once you have mineral deposits no drug is going to reverse (thermodynamics) that unless you sonicate or go in with a potent calcium chelator, those nodules are likely sticking around. I like that they did the offering around $24. Nice cash pile. Good luck
2 · Reply
ap20
ap20 May. 6 at 4:43 PM
$GLUE nothing posted this month..so I’ll stick with: Stick With GLUE.
0 · Reply
The_Gambl3r
The_Gambl3r Apr. 29 at 7:40 PM
$GLUE 👀👀👀👀👀👀
0 · Reply
cheruskian
cheruskian Apr. 28 at 8:49 PM
$SPY PSA: cup and handle patterns forming on the daily/weekly chart of several US biotechs. Check your favorite tickers and shop around a bit. E.g. waiting for confirmation breakout here $GLUE
0 · Reply
focafoca99
focafoca99 Apr. 20 at 1:40 PM
$GLUE presented AACR preclinical data supporting its CCNE1-directed molecular glue degrader in CCNE1-amplified solid tumors.
0 · Reply
LabPsycho
LabPsycho Apr. 17 at 7:47 PM
$GLUE Is 25% unusual for biotechs?
1 · Reply
MuchMillions
MuchMillions Apr. 17 at 3:28 PM
$GLUE shorts trapped!!
0 · Reply
oneyedjacks
oneyedjacks Apr. 15 at 8:38 PM
$GLUE smell a BO and that's not body odor. 😅
0 · Reply
oneyedjacks
oneyedjacks Apr. 15 at 8:37 PM
$GLUE short ratio is insane. This is being accumulated in DP
0 · Reply
Latest News on GLUE
Monte Rosa Therapeutics reports Q4 collaboration revenue $2.78M

2026-03-17T15:05:52.000Z - 2 months ago

Monte Rosa Therapeutics reports Q4 collaboration revenue $2.78M


Monte Rosa Therapeutics files automatic mixed securities shelf

2026-02-11T21:40:21.000Z - 3 months ago

Monte Rosa Therapeutics files automatic mixed securities shelf


Monte Rosa Therapeutics announces $200M common stock offering

2026-01-07T21:05:48.000Z - 4 months ago

Monte Rosa Therapeutics announces $200M common stock offering


Monte Rosa Therapeutics Transcript: Study Result

Jan 7, 2026, 8:00 AM EST - 4 months ago

Monte Rosa Therapeutics Transcript: Study Result


Monte Rosa Therapeutics announces Phase 1 data of MRT-8102

2026-01-07T12:10:51.000Z - 4 months ago

Monte Rosa Therapeutics announces Phase 1 data of MRT-8102


Monte Rosa Therapeutics Transcript: Study Result

Dec 16, 2025, 8:00 AM EST - 5 months ago

Monte Rosa Therapeutics Transcript: Study Result


Monte Rosa Therapeutics Earnings Call Transcript: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Monte Rosa Therapeutics Earnings Call Transcript: Q4 2024


This Biotech Stock Has Doubled Its Value Today—Here's Why

Oct 28, 2024, 3:06 PM EDT - 1 year ago

This Biotech Stock Has Doubled Its Value Today—Here's Why


Monte Rosa Therapeutics Announces Leadership Team Promotions

May 30, 2024, 7:00 AM EDT - 2 years ago

Monte Rosa Therapeutics Announces Leadership Team Promotions


MorganHoratio
MorganHoratio May. 8 at 1:36 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: $HYPR - 898,720 $LYEL - 293,256 $MAZE - 1,388,583 $GLUE - 684,275 $OSCR - 481,988 Google's Q1 13F reveals a sharp focus: Cybersecurity Bedrock + AI Bio-Engineering! The stake in $HYPR is a massive signal—in a 2026 defined by AI deepfakes, Google is leaning on $HYPR's passwordless tech to fortify its Gemini ecosystem. Meanwhile, the heavy lifting in $MAZE and $GLUE proves Alphabet is no longer just indexing information, but indexing "cures" through AI-led protein modeling. With $OSCR hitting its profitability inflection point, do you think Google is just building an AI-health moat, or are we looking at the early days of its next multi-billion dollar "Other Bet" breakout? Let's discuss your top small-cap pick!
3 · Reply
LabPsycho
LabPsycho May. 7 at 4:49 PM
$GLUE Frankly, IMO, while the cash and some of their assets look good, I dont get why they are going after: hidradenitis suppurativa (arent there easy do it at home ways to address much of this?) and atherosclerosis - once you have mineral deposits no drug is going to reverse (thermodynamics) that unless you sonicate or go in with a potent calcium chelator, those nodules are likely sticking around. I like that they did the offering around $24. Nice cash pile. Good luck
2 · Reply
ap20
ap20 May. 6 at 4:43 PM
$GLUE nothing posted this month..so I’ll stick with: Stick With GLUE.
0 · Reply
The_Gambl3r
The_Gambl3r Apr. 29 at 7:40 PM
$GLUE 👀👀👀👀👀👀
0 · Reply
cheruskian
cheruskian Apr. 28 at 8:49 PM
$SPY PSA: cup and handle patterns forming on the daily/weekly chart of several US biotechs. Check your favorite tickers and shop around a bit. E.g. waiting for confirmation breakout here $GLUE
0 · Reply
focafoca99
focafoca99 Apr. 20 at 1:40 PM
$GLUE presented AACR preclinical data supporting its CCNE1-directed molecular glue degrader in CCNE1-amplified solid tumors.
0 · Reply
LabPsycho
LabPsycho Apr. 17 at 7:47 PM
$GLUE Is 25% unusual for biotechs?
1 · Reply
MuchMillions
MuchMillions Apr. 17 at 3:28 PM
$GLUE shorts trapped!!
0 · Reply
oneyedjacks
oneyedjacks Apr. 15 at 8:38 PM
$GLUE smell a BO and that's not body odor. 😅
0 · Reply
oneyedjacks
oneyedjacks Apr. 15 at 8:37 PM
$GLUE short ratio is insane. This is being accumulated in DP
0 · Reply
MuchMillions
MuchMillions Apr. 15 at 7:13 PM
$GLUE woah!! 25% of float short this thing could blow!!
1 · Reply
ap20
ap20 Apr. 9 at 9:16 PM
$GLUE Looks like the tide has turned. Stick with GLUE..
0 · Reply
MuchMillions
MuchMillions Mar. 27 at 8:21 PM
$GLUE short interest back at 20% could be a powder keg on any positive news
1 · Reply
ash1012
ash1012 Mar. 25 at 4:31 PM
$GLUE pump and dump coming, sell short
1 · Reply
ash1012
ash1012 Mar. 24 at 7:45 PM
$GLUE i beleive it will drop 50 cents every day for next three days
0 · Reply
LabPsycho
LabPsycho Mar. 24 at 7:13 PM
$GLUE @ash1012 These 100k - 250k share trades, seemingly dumps, are a concern IMO. I don't think your $10 is unreasonable and is aligned of what I have been expecting. To look at it simply..not too long ago less than a year there was a base price of about $4-$5 which quickly 5X to $25 ~ 6 months. Take the average of the log(5) log(25) which is ~ log(10) - which is also about their book value. Still looking good long term if the entire market doesnt collapse but thats iffy IMO. Good luck
1 · Reply
ash1012
ash1012 Mar. 24 at 5:44 PM
$GLUE get out before it collapses to under $10.00 , sell now
0 · Reply
oneyedjacks
oneyedjacks Mar. 23 at 4:31 PM
$GLUE going back to $4
0 · Reply
LabPsycho
LabPsycho Mar. 23 at 4:03 PM
$GLUE @MuchMillions IMO, that 4million share trade at 3 pm last Friday is not a good omen. I dont think getting to $10 is unreasonable - many still up 100% in months.
0 · Reply
ap20
ap20 Mar. 23 at 2:23 PM
$GLUE Added. Stick with GLUE.
0 · Reply
MuchMillions
MuchMillions Mar. 18 at 10:19 PM
$GLUE a dip to $12ISH would be a God send
1 · Reply